Literature DB >> 10361118

Mpl ligand enhances the transcription of the cyclin D3 gene: a potential role for Sp1 transcription factor.

Z Wang1, Y Zhang, J Lu, S Sun, K Ravid.   

Abstract

Cyclin D3 plays a major role in the development of polyploidy in megakaryocytes. The expression of cyclin D3 gene and the level of cyclin D3 protein are increased by the Mpl ligand in the Y10/L8057 megakaryocytic cell line, as indicated by Northern and Western blot analyses, and by nuclear run-on assays and transfection experiments with cyclin D3 promoter constructs. DNase I footprinting of the promoter region showed protected segments, at -75 to -60 bp and at -134 to -92 bp, which display binding sites for the Sp family of transcription factors. Gel mobility shift assay and supershifts with specific antibodies indicate that Sp1 binds to these regions in the cyclin D3 promoter and that Sp1 binding activity is significantly increased by Mpl ligand. Mutation of either Sp1 site both decreases the basal promoter activity and eliminates the induction by Mpl ligand. We find that the nonphosphorylated form of SP1 has greater affinity for the cyclin D3 promoter and that the majority of Sp1 in the cells is nonphosphorylated. Mpl ligand treatment results in increased levels of Sp1 protein, which also appears as nonphosphorylated. Okadaic acid, which inhibits protein phosphatase 1 (PP1) and shifts Sp1 to a phosphorylated form, decreases cyclin D3 gene expression and suppresses Mpl ligand induction. Our data point to the potential of Mpl ligand to activate at once several Sp1-dependent genes during megakaryopoiesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10361118

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Identification of cyclin D3 as a direct target of E2A using DamID.

Authors:  Siyuan Song; Jonathan Cooperman; Danielle L Letting; Gerd A Blobel; John Kim Choi
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

2.  Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: identification of an aneuploidy-promoting property.

Authors:  Hao G Nguyen; Dharmaraj Chinnappan; Takeshi Urano; Katya Ravid
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

3.  An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles.

Authors:  J G Thomas; J M Olson; S J Tapscott; L P Zhao
Journal:  Genome Res       Date:  2001-07       Impact factor: 9.043

Review 4.  Sp1 phosphorylation and its regulation of gene transcription.

Authors:  Nicole Y Tan; Levon M Khachigian
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

5.  Inhibition of GSK-3beta promotes survival and proliferation of megakaryocytic cells through a beta-catenin-independent pathway.

Authors:  Mie Soda; Karl Willert; Kenneth Kaushansky; Amy E Geddis
Journal:  Cell Signal       Date:  2008-09-06       Impact factor: 4.315

6.  Glypican-1 stimulates Skp2 autoinduction loop and G1/S transition in endothelial cells.

Authors:  Dianhua Qiao; Kristy Meyer; Andreas Friedl
Journal:  J Biol Chem       Date:  2011-12-27       Impact factor: 5.157

7.  Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition.

Authors:  Y Tong; Y Tan; C Zhou; S Melmed
Journal:  Oncogene       Date:  2007-03-12       Impact factor: 9.867

8.  Properties of ets-1 binding to chromatin and its effect on platelet factor 4 gene expression.

Authors:  Jun Lu; Michael J Pazin; Katya Ravid
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

9.  Differential expression of NADPH oxidases in megakaryocytes and their role in polyploidy.

Authors:  Donald J McCrann; Alexia Eliades; Maria Makitalo; Kuniharu Matsuno; Katya Ravid
Journal:  Blood       Date:  2009-05-26       Impact factor: 22.113

10.  Post-translational control of sp-family transcription factors.

Authors:  J S Waby; C D Bingle; B M Corfe
Journal:  Curr Genomics       Date:  2008       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.